Plain-English translation of NCT06845202 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study is testing a new medication called to see if it can help people lose weight and manage type 2 diabetes. The trial has two parts: first, healthy volunteers who are overweight will receive a single dose to check that the medication is safe, and second, people with type 2 diabetes will receive multiple doses to see if the treatment actually works. About 144 people will participate in total.
Many people struggle with weight management and type 2 diabetes, and current treatment options don't work well for everyone. This medication is being tested because researchers believe it may offer a new way to help people control their weight and blood sugar levels.
If you join Part A, you'll visit the clinic once to receive a single injection or dose of the medication (or placebo) and have blood tests and check-ups. If you join Part B, you'll receive multiple doses of the medication (or placebo) over several weeks or months and make several clinic visits for blood tests and monitoring to see how well the treatment works. Throughout both parts, the research team will carefully watch for any side effects and measure changes in your weight and blood sugar levels.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
United States